Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiStem in Moderate to Severe Ulcerative Colitis
NCT01240915Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2011
- Primary completion
- Nov 2014
- Modality
- Stem Cell Therapies
- Countries
- 8
01
Overview
A Phase 2 trial of invimestrocel in ulcerative colitis (UC), sponsored by Pfizer. Started Feb 2011; status: completed.
02
Drugs
invimestrocel
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01240915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240915.